123 related articles for article (PubMed ID: 38192074)
1. IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients.
Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
Scand J Immunol; 2021 Dec; 94(6):e13107. PubMed ID: 38192074
[TBL] [Abstract][Full Text] [Related]
2. CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells.
Gu H; Deng W; Zheng Z; Wu K; Sun F
Immun Inflamm Dis; 2021 Dec; 9(4):1686-1695. PubMed ID: 34525267
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
4. Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies.
Torres-Ruiz J; Absalón-Aguilar A; Reyes-Islas JA; Cassiano-Quezada F; Mejía-Domínguez NR; Pérez-Fragoso A; Maravillas-Montero JL; Núñez-Álvarez C; Juárez-Vega G; Culebro-Bermejo A; Gómez-Martín D
Rheumatology (Oxford); 2023 Feb; 62(2):775-784. PubMed ID: 35766810
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma.
Sharma V; Aggarwal A; Jacob J; Sahni D
Scand J Immunol; 2021 May; 93(5):e13021. PubMed ID: 33455004
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in Patients With Acute Pancreatitis With Increased Inhibitory Function.
Ding L; Wan M; Wang D; Cao H; Wang H; Gao P
Front Immunol; 2022; 13():840620. PubMed ID: 35911709
[TBL] [Abstract][Full Text] [Related]
7. CCR4
Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
Immunobiology; 2022 May; 227(3):152210. PubMed ID: 35358941
[TBL] [Abstract][Full Text] [Related]
8. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
9. Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma.
Holokai L; Chakrabarti J; Lundy J; Croagh D; Adhikary P; Richards SS; Woodson C; Steele N; Kuester R; Scott A; Khreiss M; Frankel T; Merchant J; Jenkins BJ; Wang J; Shroff RT; Ahmad SA; Zavros Y
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348809
[No Abstract] [Full Text] [Related]
10. Role of myeloid-derived suppressor cells in chronic brucellosis.
Hou S; Kong F; Li X; Xu Y; Chen S; Zhang S; Zhang L; Li T; Fu Y; Li C; Wang W
Front Cell Infect Microbiol; 2024; 14():1347883. PubMed ID: 38352057
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
[TBL] [Abstract][Full Text] [Related]
12. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-150 inhibits myeloid-derived suppressor cells proliferation and function through negative regulation of ARG-1 in sepsis.
Liu Q; Wang Y; Zheng Q; Dong X; Xie Z; Panayi A; Bai X; Li Z
Life Sci; 2021 Aug; 278():119626. PubMed ID: 34004247
[TBL] [Abstract][Full Text] [Related]
14. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
15. Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout.
Zhong L; Li S; Wen Y; Zheng J; Liu F; Cao D; Liu Y
Front Immunol; 2020; 11():567783. PubMed ID: 33154749
[TBL] [Abstract][Full Text] [Related]
16. Modified method for differentiation of myeloid-derived suppressor cells
Zhou H; Xie Z; Morikawa N; Sakurai F; Mizuguchi H; Okuzaki D; Okada N; Tachibana M
Biochem Biophys Rep; 2023 Mar; 33():101416. PubMed ID: 36605123
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
[TBL] [Abstract][Full Text] [Related]
20. CD13
Zhang J; Xu X; Shi M; Chen Y; Yu D; Zhao C; Gu Y; Yang B; Guo S; Ding G; Jin G; Wu CL; Zhu M
Oncoimmunology; 2017; 6(2):e1258504. PubMed ID: 28344866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
